Skip to main content

Anidulafungin Disease Interactions

There is 1 disease interaction with anidulafungin.

Moderate

Echinocandins (applies to anidulafungin) hepatotoxicity

Moderate Potential Hazard, Moderate plausibility. Applicable conditions: Liver Disease

Laboratory abnormalities in liver function tests have been observed in healthy volunteers and patients treated with echinocandins, and clinical hepatic abnormalities have occurred in some patients with serious underlying conditions who were receiving multiple concomitant medications with echinocandin therapy. Isolated cases of significant hepatic dysfunction, hepatitis, or worsening hepatic failure have also been reported, although a causal relationship has not been established. Therapy with echinocandins should be administered cautiously in patients with preexisting liver disease. Liver function should be monitored regularly during therapy.

References

  1. (2001) "Product Information. Cancidas (caspofungin)." Merck & Co., Inc
  2. (2005) "Product Information. Mycamine (micafungin)." Fujisawa
  3. (2006) "Product Information. Eraxis (anidulafungin)." Pfizer U.S. Pharmaceuticals Group
  4. (2023) "Product Information. Rezzayo (rezafungin)." Melinta Therapeutics, Inc.
View all 4 references

Anidulafungin drug interactions

There is 1 drug interaction with anidulafungin.


Report options

Loading...
QR code containing a link to this page

Drug Interaction Classification

These classifications are only a guideline. The relevance of a particular drug interaction to a specific individual is difficult to determine. Always consult your healthcare provider before starting or stopping any medication.
Major Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit.
Moderate Moderately clinically significant. Usually avoid combinations; use it only under special circumstances.
Minor Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan.
Unknown No interaction information available.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.